Orthopediatrics Reports Third-Quarter 2026 Revenue of $72.7 Million
Revenue rose 18.6% year over year to $72.7 million. Net loss narrowed to $5.9 million from $11.8 million, and diluted loss per share improved to $(0.25) from $(0.50).
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Revenue rose 18.6% year over year to $72.7 million. Net loss narrowed to $5.9 million from $11.8 million, and diluted loss per share improved to $(0.25) from $(0.50).